Hemifacial spasm management: 26-year experience
Objective: To analyze the causes of hemifacial spasm as well as the efficacy and safety of long term treatment with botulinum toxin (BT). Background: Hemifacial…A case of hemimasticatory spasm with well therapeutic response to serial injections of botulinum toxin
Objective: To report a case with hemimasticatory spasm responsive to serial botulinum toxin injections. Background: Hemimasticatory spasm is a rare neurologic disorder characterized by involuntary…The effects of onabotulinum toxin on neurophysiological tests in patients with hemifacial spasm
Objective: We aimed to investigate effects of onabotulinum toxin (OnaBoNT) on clinical and neurophysiological findings of patients with hemifacial spasm (HFS). Background: There is a…Hemifacial Spasm and Related Comorbidities
Objective: In this study, we evaluated the clinical findings, comorbidities and teratment responses in our HFS patients. Background: Hemifacial spasm (HFS) is a peripherally induced…Non-motor symptoms and alteration of brain networks in patients with blepharospasm and hemifacial spasm
Objective: To investigate the differences of non-motor symptoms and the alteration of intrinsic brain networks in patients with blepharospasm and hemifacial spam. Background: Blepharospasm (BSP)…Assessing hemifacial spasm: The HFSG scale
Objective: To create and validate an objective assessing tool to diagnose and monitor HFS and the efficacy of its treatments. Background: Hemifacial spasm (HFS), is…Effect of Cold Compression Before Botulinum Neurotoxin Injection in Hemifacial Spasm
Objective: To compare effect of cold compression and no cold compression before Botulinum neurotoxin (BoNT) injection on severity, frequency of hemifacial spasm (HFS) and complication…Comparison of clinical characteristics and treatment outcomes of botulinum neurotoxin in routine clinical practice between hemifacial spasm with and without the Babinski-2 sign in Thai patients: An exploratory study
Objective: To compare the clinical characteristics, along with the treatment outcomes of botulinum neurotoxin (BoNT) between HFS patients with and without the BBK-2 sign as…The comparison of the clinical characteristics and treatment outcomes between non-troublesome and troublesome hemifacial spasm in Thai patients
Objective: To compare the clinical characteristics and treatment outcomes after injection of botulinum neurotoxin (BoNT) type A between non-troublesome and troublesome hemifacial spasm (HFS) in…What does the severity of hemifacial spasm mean to us?
Objective: We investigated the clinical meaning of the severity of hemifacial spasm (HFS) in the patients who performed microvascular decompression (MVD). Background: Even though the most…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.